Tiger is quite right. Whilst the efficacy resutls are exceptional, the safety profile is not and, in fact, I don't know how the author of the article could possibly refer to the drug as safe given the details:-
"The drug was found to be safe, with manageable side effects, including cytokine-release syndrome in four patients and immune-cell-related neurotoxicity syndrome in three patients. One patient experienced grade 3 sepsis that resolved; the same patient later developed fatal neutropenic septic shock outside the dose-limiting toxicity time frame."
The specific type of NHL being trialed is B-cell non-Hodgkin Lymphoma. From the following list of main subtypes listed on the Lymphoma Aust website, you can see where PTCL and CTCL sit;-
What's interesting is the following slide from our PTX-100 Spotlight Presentation that shows the indications of interest for PTX-100:-
- Forums
- ASX - By Stock
- PTX Media related
Tiger is quite right. Whilst the efficacy resutls are...
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.6¢ |
Change
-0.001(2.13%) |
Mkt cap ! $37.04M |
Open | High | Low | Value | Volume |
4.7¢ | 4.7¢ | 4.6¢ | $10.18K | 221.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 117117 | 4.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.7¢ | 196238 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 117117 | 0.046 |
3 | 311112 | 0.045 |
1 | 52892 | 0.044 |
7 | 471667 | 0.043 |
5 | 332618 | 0.042 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 196238 | 6 |
0.048 | 289589 | 3 |
0.049 | 134571 | 4 |
0.050 | 155539 | 3 |
0.051 | 100101 | 1 |
Last trade - 10.33am 04/06/2024 (20 minute delay) ? |
|
|||||
Last
4.7¢ |
  |
Change
-0.001 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
4.6¢ | 4.7¢ | 4.6¢ | 135177 | ||
Last updated 12.28pm 04/06/2024 ? |
Featured News
PTX (ASX) Chart |